The recent events of the global pandemic, military conflict in eastern Europe, and the increasing frequency of climatic, natural disasters have brought into sharp relief the importance of continuity planning and crisis management plans across a range of sectors. In particular, the biopharmaceutical industry has been keenly aware of these impacts on patients and those individuals participating in clinical research in impacted regions. This workshop will take a deep dive into topic areas that have been placed under pressure or arisen as potential solutions the past three years by these events: conduct of clinical trials; innovation in the conduct of research; and science/health literacy and combatting misinformation. Attendees will be given the opportunity to engage in small and large group discussion focusing on ethical considerations when conducting research during uncertain, chaotic times. This session will take place in Zoom meeting. The use of attendee video is encouraged for participation and interaction with your peers.
Learning Objectives:
Develop an understanding of the ethical considerations that affect biopharmaceutical industry decision making for clinical research during periods of disruption
Understand the global research landscape and efforts to incorporate innovative approaches to trials across distinct regions and inconsistent regulatory environments, mixing science, politics, and social justice across areas of disruption
Gain experience in applying these learnings to relevant cases and to identify questions and best practices for managing this ethically complex space